ALB and neoplasm: Based on previous studies, several pretreatment serum inflammatory markers including platelet–lymphocyte ratio (PLR), CRP albumin ratio (CAR), and systemic inflammatory response index (SIRI) are used to predict tumor progression and prognosis (11, 12).